The investment is set to propel the platform's development, which leverages cfChIP-seq technology. The platform analyses gene expression and cell states specific to individual cells from a blood ...
The funding will advance Senseera's GEM BIOMARKERSâ„¢ liquid biopsy platform, powered by cfChIP-seq technology. The platform decodes cell-specific gene expression and cell states from a simple ...